Castle Biosciences
Castle Biosciences develops and commercializes diagnostic and prognostic tests for cancers that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.

Year Established: 2007
Stock Ticker: CSTL
Exchange: NASDAQ